| Sinovial H-L Group | Triamcinolone Group | p value |
---|---|---|---|
(N = 55) | (N = 45) | ||
Age (years) | 68.6 ± 9.4 | 65.5 ± 9.9 | 0.127 |
Sex, no. male/female | 20/35 | 12/33 | 0.261 |
% with dominant right hand | 100 | 100 | 1.000 |
BMI (kg/m2) | 24.4 ± 4.0 | 24.4 ± 3.8 | 0.761 |
Disease duration (months) | 88.65 ± 68.21 | 92.7 ± 62.7 | 0.179 |
Radiographic Score (K-L grade) no. (%) | |||
 II | 30 (54) | 25 (56) | 0.963 |
 III | 25 (46) | 20 (44) | 0.851 |
Marital status, no. (%) | |||
 Unmarried | 4 (7.2) | 4 (8.8) |  |
 Married | 42 (76.5) | 36 (80.0) |  |
 Widow | 5 (9.1) | 2 (4.4) |  |
 Divorced | 4 (7.2) | 3 (6.8) | 0.628 |
Education, no. (%) | |||
 None | 2 (3.6) | 3 (6.6) |  |
 Primary | 12 (21.8) | 6 (13.3) |  |
 Middle | 15 (27.27) | 8 (17.7) |  |
 High | 19 (34.54) | 25 (55.8) |  |
 University | 7 (12.79) | 3 (6.6) | 0.383 |
No. (%) of smokers | 1 (1.81) | 6 (13.3) | 0.035 |
No. (%) of patients with diabetes | 1 (1.81) | 8 (17.7) | 0.009 |
No. (%) of patients with cardiovascular disease | 3 (5.4) | 4 (8.8) | 0.598 |
No. (%) of patients with hypertension | 22 (40.0) | 20 (44.4) | 1.000 |
No. (%) of patients with tyroid disease | 8 (14.5) | 10 (22.2) | 0.447 |
Total Cholesterol (mg/dL) | 220.2 ± 36.3 | 208.8 ± 39.1 | 0.006 |
LDL Cholesterol (mg/dL) | 143.2 ± 30.5 | 134.2 ± 28.1 | 0.004 |
HDL Cholesterol (mg/dL) | 63.5 ± 17.2 | 64.3 ± 18.0 | 0.781 |
Triglycerides (mg/dL) | 139.7 ± 47.6 | 137.7 ± 50.1 | 0.410 |
ESR (mm/h) | 16.2 ± 11.6 | 18.3 ± 12.2 | 0.081 |
CRP (mg/dL) | 0.19 ± 0.29 | 0.3 ± 0.33 | 0.094 |
Glycemia (mg/dL) | 94.7 ± 14.1 | 96.9 ± 17.9 | 0.371 |
VAS Pain (mm) (0–100) | 58.5 ± 16.2 | 61.8 ± 17.6 | 0.320 |
VAS Stiffness (min) | 9.7 ± 11.8 | 8.9 ± 4.1 | 0.185 |
FIHOA (0–30) | 12.2 ± 4.3 | 12.9 ± 4.2 | 0.485 |
SF-36 PCS | 35.9 ± 9.5 | 38.3 ± 8.7 | 0.191 |
SF-36 MCS | 50.4 ± 7.7 | 41.4 ± 9.5 | 0.001 |
HAQ (0–3) | 0.82 ± 0.44 | 0.88 ± 0.47 | 0.704 |